Literature DB >> 8554046

Identification of 13 new mutations in the vasopressin-neurophysin II gene in 17 kindreds with familial autosomal dominant neurohypophyseal diabetes insipidus.

S Rittig1, G L Robertson, C Siggaard, L Kovács, N Gregersen, J Nyborg, E B Pedersen.   

Abstract

Familial neurohypophyseal diabetes insipidus (FNDI) is an autosomal dominant disorder characterized by progressive postnatal deficiency of arginine vasopressin as a result of mutation in the gene that encodes the hormone. To determine the extent of mutations in the coding region that produce the phenotype, we studied members of 17 unrelated kindreds with the disorder. We sequenced all 3 exons of the gene by using a rapid, direct dye-terminator method and found the causative mutation in each kindred. In four kindreds, the mutations were each identical to mutations described in other affected families. In the other 13 kindreds each mutation was unique. There were two missense mutations that altered the cleavage region of the signal peptide, seven missense mutations in exon 2, which codes for the conserved portion of the protein, one nonsense mutation in exon 2, and three nonsense mutations in exon 3. These findings, together with the clinical features of FNDI, suggest that each of the mutations exerts an effect by directing the production of a pre-prohormone that cannot be folded, processed, or degraded properly and eventually destroys vasopressinergic neurons.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8554046      PMCID: PMC1914959     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  53 in total

1.  Familial diabetes insipidus.

Authors:  F I MARTIN
Journal:  Q J Med       Date:  1959-10

Review 2.  Proteolysis in protein import and export: signal peptide processing in eu- and prokaryotes.

Authors:  M Müller
Journal:  Experientia       Date:  1992-02-15

3.  Maturation of Escherichia coli maltose-binding protein by signal peptidase I in vivo. Sequence requirements for efficient processing and demonstration of an alternate cleavage site.

Authors:  J D Fikes; G A Barkocy-Gallagher; D G Klapper; P J Bassford
Journal:  J Biol Chem       Date:  1990-02-25       Impact factor: 5.157

4.  Possible involvement of inefficient cleavage of preprovasopressin by signal peptidase as a cause for familial central diabetes insipidus.

Authors:  M Ito; Y Oiso; T Murase; K Kondo; H Saito; T Chinzei; M Racchi; M O Lively
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

5.  A single base substitution in the coding region for neurophysin II associated with familial central diabetes insipidus.

Authors:  M Ito; Y Mori; Y Oiso; H Saito
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

6.  Plasma vasopressin in hereditary cranial diabetes insipidus.

Authors:  I Os; I Aakesson; E Enger
Journal:  Acta Med Scand       Date:  1985

7.  Glu-47, which forms a salt bridge between neurophysin-II and arginine vasopressin, is deleted in patients with familial central diabetes insipidus.

Authors:  H Yuasa; M Ito; H Nagasaki; Y Oiso; S Miyamoto; N Sasaki; H Saito
Journal:  J Clin Endocrinol Metab       Date:  1993-09       Impact factor: 5.958

8.  Specific diagnosis of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in dried blood spots by a polymerase chain reaction (PCR) assay detecting a point-mutation (G985) in the MCAD gene.

Authors:  N Gregersen; A I Blakemore; V Winter; B Andresen; S Kølvraa; L Bolund; D Curtis; P C Engel
Journal:  Clin Chim Acta       Date:  1991-11-09       Impact factor: 3.786

9.  Radioimmunoassay of vasopressin in familial cental diabetes insipidus.

Authors:  P B Kaplowitz; A J D'Ercole; G L Robertson
Journal:  J Pediatr       Date:  1982-01       Impact factor: 4.406

10.  SEC11 is required for signal peptide processing and yeast cell growth.

Authors:  P C Böhni; R J Deshaies; R W Schekman
Journal:  J Cell Biol       Date:  1988-04       Impact factor: 10.539

View more
  22 in total

1.  Clinical and molecular analysis of a Chinese family with autosomal dominant neurohypophyseal diabetes insipidus associated with a novel missense mutation in the vasopressin-neurophysin II gene.

Authors:  Yongfeng Luo; Binbin Wang; Yu Qiu; Chuan Zhang; Chengluo Jin; Yakun Zhao; Qingguo Zhu; Xu Ma
Journal:  Endocrine       Date:  2012-02-04       Impact factor: 3.633

2.  Structural Requirements for Sorting Pro-Vasopressin to the Regulated Secretory Pathway in a Neuronal Cell Line.

Authors:  David R Cool; Steven B Jackson; Karen S Waddell
Journal:  Open Neuroendocrinol J       Date:  2008-01-01

Review 3.  Familial forms of diabetes insipidus: clinical and molecular characteristics.

Authors:  Muriel Babey; Peter Kopp; Gary L Robertson
Journal:  Nat Rev Endocrinol       Date:  2011-07-05       Impact factor: 43.330

4.  A novel heterozygous missense mutation in the vasopressin moiety is identified in a Japanese person with neurohypophyseal diabetes insipidus.

Authors:  H Kobayashi; I Fujisawa; K Ikeda; C Son; T Iwakura; A Yoshimoto; M Kasahara; T Ishihara; Y Ogawa
Journal:  J Endocrinol Invest       Date:  2006-03       Impact factor: 4.256

5.  Molecular basis of autosomal dominant neurohypophyseal diabetes insipidus. Cellular toxicity caused by the accumulation of mutant vasopressin precursors within the endoplasmic reticulum.

Authors:  M Ito; J L Jameson; M Ito
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

6.  Contributions of the interdomain loop, amino terminus, and subunit interface to the ligand-facilitated dimerization of neurophysin: crystal structures and mutation studies of bovine neurophysin-I.

Authors:  Xintian Li; Hunjoong Lee; Jin Wu; Esther Breslow
Journal:  Protein Sci       Date:  2007-01       Impact factor: 6.725

Review 7.  ER-associated degradation in health and disease - from substrate to organism.

Authors:  Asmita Bhattacharya; Ling Qi
Journal:  J Cell Sci       Date:  2019-12-02       Impact factor: 5.285

8.  ER-associated degradation is required for vasopressin prohormone processing and systemic water homeostasis.

Authors:  Guojun Shi; Diane RM Somlo; Geun Hyang Kim; Cristina Prescianotto-Baschong; Shengyi Sun; Nicole Beuret; Qiaoming Long; Jonas Rutishauser; Peter Arvan; Martin Spiess; Ling Qi
Journal:  J Clin Invest       Date:  2017-09-18       Impact factor: 14.808

9.  AVP-NPII gene mutations and clinical characteristics of the patients with autosomal dominant familial central diabetes insipidus.

Authors:  Doga Turkkahraman; Emel Saglar; Tugce Karaduman; Hatice Mergen
Journal:  Pituitary       Date:  2015-12       Impact factor: 4.107

10.  A murine model of autosomal dominant neurohypophyseal diabetes insipidus reveals progressive loss of vasopressin-producing neurons.

Authors:  Theron A Russell; Masafumi Ito; Mika Ito; Richard N Yu; Fred A Martinson; Jeffrey Weiss; J Larry Jameson
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.